Clinical, Cosmetic and Investigational Dermatology (Jan 2020)
Depression and Anxiety in Patients with Bullous Pemphigoid: Impact and Management Challenges
Abstract
Nicolas Kluger, Anna Pankakoski, Jaana Panelius Department of Dermatology, Allergology and Venereology, Helsinki University Hospital, Helsinki, FinlandCorrespondence: Nicolas KlugerDepartment of Dermatology, Skin and Allergies Hospital, Meilahdentie 2, PO Box 160, Helsinki 00029 HUS, FinlandEmail [email protected]: Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. It is also associated with high mortality and poor prognosis due to advanced age of the patients and coexisting comorbidities. There is a dearth of data in the literature regarding depression and anxiety among those patients. The objective of this brief review is to discuss the intertwining relationship between depression and anxiety with bullous pemphigoid.Keywords: anxiety, bullous pemphigoid, corticosteroids, depression, drug-induced bullous pemphigoid, quality of life
